Posted by Michael Wonder on 24 Jan 2022
EMA publishes agenda for 24-27 Jan CHMP meeting
23 January 2022 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Lisocabtagene maraleucel
- Dasatinib monohydate
- Trastuzumab
- Nirmatrelvir and ritonavir
- Doxorubicin hydrochloride
- Teriparatide
- Pegfilgrastim
- Vildagliptin with metformin hydrochloride
